Milvexian is a factor XIa inhibitor anticoagulant drug. It is taken by mouth. As of late 2021, it was under study for the prevention of blood clots in patients…
Milvexian is a factor XIa inhibitor anticoagulant drug. It is taken by mouth. As of late 2021, it was under study for the prevention of blood clots in patients undergoing surgery. In 2018–2023, Bristol-Myers Squibb studied milvexian for the prevention of stroke.
References
Gebaseerd op: Wikipedia — Milvexian · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.